Insider · CIK 0002017200
Monica Bhargava
presidentofficer
Files at WSM (WILLIAMS SONOMA INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Common Stock | +3,246 | $0.00 | $0 | 20,741 | Aug 5, 2025 |
| Aug 1, 2025 | WSM WILLIAMS SONOMA INC | FTax withholding Common Stock | -1,649 | $187.05 | $308k | 19,092 | Aug 5, 2025 |
| Aug 1, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Restricted Stock Unitsderivative | -3,246 | $0.00 | $0 | 6,492 | Aug 5, 2025 |
| Apr 15, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Common Stock | +1,622 | $0.00 | $0 | 18,319 | Apr 17, 2025 |
| Apr 15, 2025 | WSM WILLIAMS SONOMA INC | FTax withholding Common Stock | -824 | $145.26 | $120k | 17,495 | Apr 17, 2025 |
| Apr 15, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Restricted Stock Unitsderivative | -1,622 | $0.00 | $0 | 0 | Apr 17, 2025 |
| Apr 4, 2025 | WSM WILLIAMS SONOMA INC | AGrant or award Restricted Stock Unitsderivative | +10,802 | $0.00 | $0 | 10,802 | Apr 10, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Common Stock | +7,709 | $0.00 | $0 | 14,769 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | FTax withholding Common Stock | -3,915 | $164.99 | $646k | 10,854 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Common Stock | +2,132 | $0.00 | $0 | 12,986 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | FTax withholding Common Stock | -1,083 | $164.99 | $179k | 11,903 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Common Stock | +7,348 | $0.00 | $0 | 19,251 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | FTax withholding Common Stock | -3,732 | $164.99 | $616k | 15,519 | Mar 25, 2025 |
| Mar 22, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Common Stock | +2,394 | $0.00 | $0 | 17,913 | Mar 25, 2025 |
| Mar 22, 2025 | WSM WILLIAMS SONOMA INC | FTax withholding Common Stock | -1,216 | $163.65 | $199k | 16,697 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | AGrant or award Restricted Stock Unitsderivative | +7,709 | $0.00 | $0 | 7,709 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Restricted Stock Unitsderivative | -7,709 | $0.00 | $0 | 0 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Restricted Stock Unitsderivative | -2,132 | $0.00 | $0 | 2,132 | Mar 25, 2025 |
| Mar 21, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Restricted Stock Unitsderivative | -7,348 | $0.00 | $0 | 14,696 | Mar 25, 2025 |
| Mar 22, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Restricted Stock Unitsderivative | -2,394 | $0.00 | $0 | 7,186 | Mar 25, 2025 |
| Jan 25, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Common Stock | +8,300 | $0.00 | $0 | 10,599 | Jan 28, 2025 |
| Jan 25, 2025 | WSM WILLIAMS SONOMA INC | FTax withholding Common Stock | -3,539 | $213.60 | $756k | 7,060 | Jan 28, 2025 |
| Jan 25, 2025 | WSM WILLIAMS SONOMA INC | MOption exercise Restricted Stock Unitsderivative | -8,300 | $0.00 | $0 | 16,598 | Jan 28, 2025 |
| Oct 26, 2024 | WSM WILLIAMS SONOMA INC | MOption exercise Common Stock | +1,420 | $0.00 | $0 | 3,019 | Oct 29, 2024 |
| Oct 26, 2024 | WSM WILLIAMS SONOMA INC | FTax withholding Common Stock | -720 | $134.76 | $97k | 2,299 | Oct 29, 2024 |
| Oct 26, 2024 | WSM WILLIAMS SONOMA INC | MOption exercise Restricted Stock Unitsderivative | -1,420 | $0.00 | $0 | 0 | Oct 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.